Guardian Bio
Company

Guardian Bio

Biotechnology 3 employees
Employees
3
Contacts
1
Emails
1

Guardian Bio Overview

Industry
Biotechnology
Employees
3
Founded
2022
Funding
500.0K
Keywords

About Guardian Bio

The Problem: Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells in particular are the generals of the immune system, directing and dictating immune responses. So it comes as no surprise that data has shown that dendritic cells are often dysfunctional in cancer patients. Guardian Bio's Solution: At Guardian Bio, our approach is focused on creating a personalized cell therapy based on dendritic cells. Our product drives anti-tumor activity through eliciting a diverse yet targeted immune response - mobilizing the entire army for the fight. We take stem cells from patients and turn them into cancer-targeted dendritic cells. Injecting our product back into patients will revitalize their immune system and give it the help it needs to win.

Guardian Bio Contact Details

People in AeroLeads
2
With contact data
1
Email contacts
1
50.0% coverage

Guardian Bio Org Chart

Sample employees and titles
Name Title Contact
Max Krummel Ucsf Professor, Founder and Partner
View
Richard Barrett, Phd. Eir at Collage Venture Partners
Email

Compare Similar Companies to Guardian Bio